Vanguard Global Advisers’s SpyGlass Pharma SGP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$75.6K Sell
2,909
-1,718
-37% -$42.3K ﹤0.01% 2900
2026
Q2
$103K Sell
4,627
-300
-6% -$6.51K ﹤0.01% 2768
2026
Q1
$128K Buy
+4,927
New +$133K ﹤0.01% 2632

Other funds holding SGP

Vanguard Global Advisers's SGP Position: Q3 2026 in Review

Vanguard Global Advisers reduced its SpyGlass Pharma (SGP) stake by 37% in Q3 2026, selling an estimated $42.3K and leaving 2,909 shares worth $75.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2900.

Vanguard Global Advisers first reported a position in SGP in Q1 2026 and has held it in 3 quarters since. The position peaked at $128K in Q1 2026. 70 funds tracked by Wall St. Rank hold SGP as of Q3 2026.

  • Vanguard Global Advisers held 2,909 shares of SpyGlass Pharma worth $75.6K as of Q3 2026.
  • Vanguard Global Advisers sold 1,718 SpyGlass Pharma shares in Q3 2026, an estimated $42.3K.
  • SpyGlass Pharma made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2900 holding.
  • Vanguard Global Advisers first reported a position in SpyGlass Pharma in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's SpyGlass Pharma position peaked at $128K in Q1 2026.
  • 70 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.